Tag

Biogen v. Mylan

Written Description: Are We Headed for a New Era of Heightened Messier Requirements?

At least pharmaceutical patents in the US may be headed for more stringent application of written description requirements as well as a more confusing unfocused...

Categories

MWZB Newsletter Signup

Subscribe